Aventura Private Wealth’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$630 Hold
9
﹤0.01% 919
2026
Q1
$457 Hold
9
﹤0.01% 854
2025
Q4
$265 Hold
9
﹤0.01% 826
2025
Q3
$232 Hold
9
﹤0.01% 782
2025
Q2
$248 Sell
9
-5
-36% -$132 ﹤0.01% 751
2025
Q1
$397 Sell
14
-1
-7% -$35 ﹤0.01% 730
2024
Q4
$624 Buy
+15
New +$717 ﹤0.01% 672

Other funds holding MRNA

Aventura Private Wealth's MRNA Position: Q2 2026 in Review

Aventura Private Wealth held its Moderna (MRNA) position steady in Q2 2026 at 9 shares worth $630. The position accounts for ﹤0.01% of the portfolio, ranked #919.

Aventura Private Wealth first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 779 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Aventura Private Wealth held 9 shares of Moderna worth $630 as of Q2 2026.
  • Aventura Private Wealth left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #919 holding.
  • Aventura Private Wealth first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 779 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.